The stock has had a terrific year, but RBC analyst Paul Treiber thinks there is still money to be made on Celestica (Celestica Stock Quote, Chart, News, Analysts, Financials NYSE:CLS).
In a research update to clients July 25, Treiber maintained his “Buy” rating and price target of $65.00 on CLS.
On July 24, CLS reported its Q2, 2024 results. The company posted EPS of $0.83 on revenue of $2.39-billion, a topline that was up 23% year-over-year.
“We are pleased to deliver another quarter of very strong performance in Q2 2024, with revenue up 23% year-to-year and non-IFRS adjusted EPS* up 65% year-to-year”. CEO Rob Mionis said. “With our strong performance in the first half of the year and favorable demand dynamics continuing, we are pleased to raise our full year 2024 outlook. We anticipate achieving revenue of $9.45 billion and non-IFRS adjusted EPS* of $3.62 in 2024, which, if achieved, would represent 19% and 49% growth, respectively, compared to 2023. We continue to stay focused on solid execution for our customers, and delivering on our strategic priorities and financial targets.”
Following the company's fourth quarter results, RBC analyst Drew McReynolds has raised his price target on Telus (Telus Stock Quote,… [Read More]
Following the company's second quarter results, RBC analyst Drew McReynolds has raised his price target on WildBrain (WildBrain Stock Quote,… [Read More]
Following the company's first quarter results, Haywood analyst Neal Gilmer has cut his price target on Organigram (Organigram Stock Quote,… [Read More]
Its third quarter results are in the books and National Bank Financial analyst Richard Tse still thinks there is money… [Read More]
Following the company's most recent quarterly results, National Bank Financial analyst Richard Tse has maintained his "Outperform" rating on Shopify… [Read More]
Its dividend is no more, but Paradigm Capital analyst Alexandra Ricci thinks there are still plenty of reasons to like… [Read More]